# Francis J. Giles

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/francis-j-giles/

## Facts

| Field | Value |
| --- | --- |
| Citations | 57,723 |
| Field | Chronic Myeloid Leukemia Treatments |
| h-index | 127 |
| i10-index | 598 |
| OpenAlex ID | https://openalex.org/A5061285204 |
| ORCID iD | https://orcid.org/0000-0002-6919-0231 |
| Works | 1,183 |

## Researcher papers

- [Chemoimmunotherapy With Fludarabine, Cyclophosphamide, and Rituximab for Relapsed and Refractory Chronic Lymphocytic Leukemia](https://scholariq.org/papers/chemoimmunotherapy-with-fludarabine-cyclophosphamide-and-rituximab-for-relapsed/)
- [A first-in-human phase 0 clinical study of RNA interference–based spherical nucleic acids in patients with recurrent glioblastoma](https://scholariq.org/papers/a-first-in-human-phase-0-clinical-study-of-rna-interference-based-spherical/)
- [Clinical Outcomes and Prognostic Factors in Patients With Richter's Syndrome Treated With Chemotherapy or Chemoimmunotherapy With or Without Stem-Cell Transplantation](https://scholariq.org/papers/clinical-outcomes-and-prognostic-factors-in-patients-with-richter-s-syndrome/)
- [Peripheral artery occlusive disease in chronic phase chronic myeloid leukemia patients treated with nilotinib or imatinib](https://scholariq.org/papers/peripheral-artery-occlusive-disease-in-chronic-phase-chronic-myeloid-leukemia/)

## Researcher topics

- [Chronic Myeloid Leukemia Treatments](https://scholariq.org/topics/chronic-myeloid-leukemia-treatments/)
- [Chronic Lymphocytic Leukemia Research](https://scholariq.org/topics/chronic-lymphocytic-leukemia-research/)
- [Acute Myeloid Leukemia Research](https://scholariq.org/topics/acute-myeloid-leukemia-research/)
- [Eosinophilic Disorders and Syndromes](https://scholariq.org/topics/eosinophilic-disorders-and-syndromes/)
- [Acute Lymphoblastic Leukemia research](https://scholariq.org/topics/acute-lymphoblastic-leukemia-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.